Ep. 87: Biomarker-based diagnosis of Alzheimer

eanCast: Weekly Neurology
10/03/2024 23 min
Ep. 87: Biomarker-based diagnosis of Alzheimer

Listen "Ep. 87: Biomarker-based diagnosis of Alzheimer"

Descargar episodio Ver en sitio original

Episode Synopsis

Moderator: Youssuf Saleh (Oxford, United Kingdom)
Guest: Sebastiaan Engelborghs (Brussel, Belgium)
Youssuf Saleh interviews Prof. Sebastiaan Engelborghs on Alzheimer's biomarkers, focusing on amyloid and tau. They discuss diagnostic challenges, the need for prognostic markers, and potential serum markers like neurofilament light. Engelborghs highlights Alzheimer's complexity and the role of omics studies in patient subpopulations. The interview concludes with optimism for blood-based biomarkers revolutionizing diagnosis in the next five years, contingent on clinical validation and evolving therapies.

More episodes of the podcast eanCast: Weekly Neurology

Ep. 175: Acute Ischemic Stroke: Evolving Guidelines and Clinical Decisions 16/11/2025
Ep. 174: Breakthrough Stroke: Diagnostic and Therapeutic Dilemmas 09/11/2025
Ep. 173: Acute Intracerebral Haemorrhage: Modern Management Strategies 02/11/2025
Ep. 172: Brain health ambassadors: bridging advocacy and action into neurology 26/10/2025
Ep. 171: AI: A Virtual Elephant in the Room or a Game-Changer in Neuroscience? 19/10/2025
Ep. 170: AI: Does it really concern neurologists? 12/10/2025
Ep. 169: Cerebral circulation in space conditions and relationship to premature cerebrovascular ageing 05/10/2025
Ep. 168: Making Sense of the New ICD-11 Classification of Chronic Pain - From Concept to Clinical Practice 28/09/2025
Ep. 167: Phantom Limb Pain - The Vanished Passenger 21/09/2025
Ep. 166: Pain When There Is a Neurodegeneration in the Brain – Assessment and Management of Pain in People with Dementia 15/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA